RIGL

Rigel Pharmaceuticals Inc. (New)

48.13

USD

-0.69

-1.41%

Sep 23, 16:00 UTC -4

Closed

After-Market

49.12

+0.99

+2.06%

RIGL Earnings Reports

Positive Surprise Ratio

RIGL beat 31 of 43 last estimates.

72%

Next Report

Date of Next Report

Nov 02, 2026

Estimate for Q3 26 (Revenue/ EPS)

$81.70M

$0.85

Implied change from Q2 26 (Revenue/ EPS)

+3.81%

-3.41%

Implied change from Q3 25 (Revenue/ EPS)

+17.62%

-41.78%

Rigel Pharmaceuticals Inc. (New) earnings per share and revenue

On Aug 04, 2026, RIGL reported earnings of 0.88 USD per share (EPS) for Q2 26, beating the estimate of 0.63 USD, resulting in a 39.15% surprise. Revenue reached 78.70 million, compared to an expected 70.85 million, with a 11.08% difference. The market reacted with a +4.60% price change (close before vs. close after earnings).

Looking ahead to Q3 26, -- analysts forecast an EPS of 0.85 USD, with revenue projected to reach 81.70 million USD, implying an decrease of -3.41% EPS, and increase of 3.81% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Champions Oncology, Inc.

Report Date

Sep 10, 2026 For Q1 27

Estimate

-$0.01

Actual

-$0.03

Surprise

-194.12%

PharmaCyte Biotech, Inc. Common Stock

Report Date

Sep 14, 2026 For Q1 27

Estimate

Actual

-$0.54

Surprise

FAQ

What were Rigel Pharmaceuticals Inc. (New)'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Rigel Pharmaceuticals Inc. (New) reported EPS of $0.88, beating estimates by 39.15%, and revenue of $78.70M, 11.08% above expectations.

How did the market react to Rigel Pharmaceuticals Inc. (New)'s Q2 2026 earnings?

The stock price moved up 4.6%, changed from $38.70 before the earnings release to $40.48 the day after.

When is Rigel Pharmaceuticals Inc. (New) expected to report next?

The next earning report is scheduled for Nov 02, 2026.

What are the forecasts for Rigel Pharmaceuticals Inc. (New)'s next earnings report?

Based on -- analysts, Rigel Pharmaceuticals Inc. (New) is expected to report EPS of $0.85 and revenue of $81.70M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.